Coronary spasm is well known to play an important role in acute myocardial infarction (AMI) patients (1) (2) (3) . In vasospastic angina (VSA) patients, AMI occurs not only in significant atherosclerotic coronary artery disease but also in the absence of coronary stenosis (4) . A previous study (5) has identified aggravated VSA as a risk factor for AMI and cardiac death. It has been reported that coronary spasm is a trigger of coronary thrombus and subsequent AMI (6) . On the other hand, it has been reported that persistent vasospastic activity is closely associated with progressive atherosclerosis in VSA patients (7) . Coronary spasm is an important factor behind the progression of coronary atherosclerosis and subsequent AMI.
Provocation testing frequently provokes coronary spasms in AMI patients (2) . Pristipino et al. (3) reported that Japanese AMI patients show a 3-fold greater incidence of acetylcholine (ACh)-induced spasms than Caucasians. It thus seems that coronary spasms are particularly important triggers of AMI in Japanese patients (8) .
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Although many reports have been published on the prognosis of VSA patients (4, 5, 7, 8) , none have focused on the prognostic significance of provoked coronary spasm in AMI patients. For further insight, our group investigated whether ACh-provoked coronary spasms are associated with adverse outcomes in Japanese AMI patients. This study is the first single-center registry conducted chiefly to evaluate the significance of provoked coronary spasms for long-term prognosis after AMI.
Methods
Patients and follow-up protocol. In the population of patients admitted to Showa University Fujigaoka Hospital with a diagnosis of AMI between January 1, 1999, and September 30, 2004, emergent PCI was successfully administered within 24 h from onset in 373 consecutive patients. Of those 373 patients, 130 met 1 or more of the following exclusion criteria and were thus excluded: in-hospital death, cardiopulmonary arrest, coronary artery bypass graft, cardiogenic shock, stroke, subacute thrombosis, or renal failure. Patients with residual stenosis received additional percutaneous coronary intervention (PCI) at the discretion of attending physicians. The remaining 243 patients underwent spasm provocation tests using ACh, and the clinical courses of 240 of them could be followed up through charts and interviews. A major adverse cardiac event (MACE) was defined as death, acute coronary syndrome (ACS), or revascularization. Cardiovascular death was defined as death caused by either cardiovascular disease or stroke, or documented as sudden cardiac death.
The study protocol was approved by the ethics committee of Showa University, and informed consent was obtained from every patient. Provocative protocol. The patients underwent provocation tests using ACh from 10 to 20 days after the onset of AMI. Calcium-channel blockers and nitrates were discontinued for at least 24 h before the tests were performed.
The provocative protocol has been previously described (3). After coronary angiography to obtain control data, ACh was injected in incremental doses of 20 and 50 g into the right coronary artery and 50 and 100 g into the left coronary artery, with support of temporary right ventricular pacing. Coronary angiography was repeated thereafter. After injection of isosorbide dinitrate, coronary angiography was repeated. Coronary spasm was defined as a transient total or subtotal reduction of the luminal diameter with electrocardiographic changes (significant ST-segment elevation [Ͼ0.1 mV] or STsegment depression [horizontal or sagging ϽϪ0.1 mV, upsloping ϽϪ2.0 mV] in Ն2 leads) and/or typical chest oppression. Statistical analysis. Continuous variables were presented as mean Ϯ SD and compared using the Student t test. Categorical variables were presented as counts and percentages, and compared using the Fisher exact probability test. A multivariate Cox regression analysis was performed to identify independent predictors of MACE. The cumulative incidence of MACE was estimated using the Kaplan-Meier method. For patients who experienced multiple events, survival analysis was restricted to the first event. Statistical significance was assumed if the null hypothesis could be rejected at the level of p ϭ 0.05. Values are mean Ϯ SD or n (%). ACEI ϭ angiotensin-converting enzyme inhibitors; ACh ϭ acetylcholine; ARB ϭ angiotensin receptor blockers; CAD ϭ coronary artery disease; CCB ϭ calcium-channel blockers; LAD ϭ left anterior descending artery; LCX ϭ left circumflex artery; LMT ϭ left main tract; LVEF ϭ left ventricular ejection fraction; MI ϭ myocardial infarction; NS ϭ not significant; RCA ϭ right coronary artery.
Results
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Provoked Coronary Spasm comparison of medications, the positive group received significantly more calcium-channel blockers (p Ͻ 0.05) and fewer beta-blockers (p Ͻ 0.05) than the negative group. All patients were given aspirin (100 to 200 mg/day) during the follow-up period. Clinical determinants of prognosis. One hundred patients experienced MACE, and 14 patients died during follow-up. The causes of death were cardiovascular disease in 4 patients, cancer in 7, infection in 2, and acute pancreatitis in 1. Table 2 compares the incidence of MACE between the 2 groups; MACE was significantly more frequent in the positive group than in the negative group (p Ͻ 0.01). Revascularization and ACS were significantly more frequent in the positive group than in the negative group (p Ͻ 0.05).
The Fisher exact probability test for MACE was performed among the following variables: spasm provocation test, age, gender, hypertension, diabetes mellitus, hyperlipidemia, smoking, prior myocardial infarction, left ventricular ejection fraction, 3-vessel disease, and medications at discharge (angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers, calcium-channel blockers, beta-blockers, and nitrates). Significant differences were found in provoked coronary spasm, hypertension, 3-vessel disease, and nitrates (Table 3) . A multivariate Cox regression analysis was performed to identify independent predictors of MACE among the factors related to provoked spasm (gender and smoking) ( Table 1) , and the significant factors related to MACE (provoked coronary spasm, hypertension, 3-vessel disease, and nitrates) ( Table 3) . Table 4 presents the results of a multivariate Cox regression analysis of MACE. Provoked coronary spasm was the strongest predictor of MACE in the multivariate analysis. Figure 1 compares the cumulative proportions of patients without MACE in the positive and the negative groups. The frequency of MACE-free survival was significantly lower in the positive group than in the negative group (p ϭ 0.0018). Relationship between the spasm-positive artery and the advance of coronary lesions. The incidences of target vessel revascularization (TVR), de novo lesions, and ACS were compared between the spasm-positive arteries and spasm-negative arteries.
In 199 spasm-positive arteries and 99 spasm-negative arteries during the first hospitalization, PCIs were performed for culprit lesions of AMI and residual stenosis. More frequently, TVR was performed in the spasm-positive arteries (63 of 199, 31.7%) than in the spasm-negative arteries (18 of 99, 18.2%) (p Ͻ 0.05) (Fig. 2A) . In the spasm-positive arteries, ACS was observed more frequently (10 of 400 [4 IRAs and 6 non-IRAs], 2.5%) than in the spasm-negative arteries (0 of 301, 0%) (p Ͻ 0.01) (Fig. 2B) . Revascularized de novo lesions including ACS were more frequent in the spasm-positive arteries (25 in 400, 6.3%) than in the spasm-negative arteries (3 in 301, 0%) (p Ͻ 0.001) (Fig. 2C) .
Discussion
This is the first report to show that provoked coronary spasms are closely associated with the prognosis of AMI patients. The incidence of provoked coronary spasms in the present study was similar to that in the previous study on Japanese AMI patients (3). The MACE-free survival was
Comparison of Cardiovascular Events Between the Positive Group and the Negative Group Death indicates cardiovascular death/total death (%). Revascularization includes PCI and/or CABG, values are n (%). ACS ϭ acute coronary syndrome; CABG ϭ coronary artery bypass graft; MACE ϭ major adverse cardiac events; PCI ϭ percutaneous coronary intervention; other abbreviations as in Table 1 . Tables 1 and 2 .
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Multivariate Cox Regression Analyses less frequent in the positive group than in the negative group. The incidences of ACS and revascularization were significantly higher in the positive group than in the negative group. In the analyses of advance of coronary lesions, TVR and de novo lesions were more frequent in the spasm-positive arteries than in the spasm-negative arteries. Also, ACS was more frequent in the spasm-positive arteries than in the spasm-negative arteries, suggesting that provoked coronary spasms may be predictive of ACS. In the present study, TVR, ACS, and de novo lesions were more frequent in the spasm-positive arteries than in the spasm-negative arteries. The first possible explanation for the results is the involvement of inflammation and fibrosis in coronary arteries. Repeated episodes of coronary spasm may provoke vascular injury, and thus lead to neointimal hyperplasia and progressive atherosclerosis. Previous studies have shown the presence of various inflammatory cells and mast cells in the adventitia of coronary arteries of patients with spasms (9). The second possible explanation is the involvement of hemorrhaging of the coronary arteries. Reports in swine models have shown that strong coronary spasms induce histological intramural hemorrhaging and intimal thickening, conditions that frequently progress to the rapid advance of coronary atherosclerosis (10). Ogawa et al. (6) reported high plasma levels of fibrinopeptide A, a sensitive marker of thrombin production that appears in the coronary circulation after coronary spasm attacks in VSA patients. Coronary spasms trigger coronary thrombus and subsequent AMI.
The previous experimental studies (10, 11) and clinical studies (7, 12) have suggested a causal link between repeated coronary spasms and atherogenesis. Intravascular ultrasound studies by Hong et al. (13) revealed intimal plaque at sites of focal coronary spasms in VSA patients. Those plaques were mostly hypoechoic and highly eccentric, with no calcification and only mild reference vessel disease. These findings Figure 1 Kaplan-Meier Curves for MACE-Free Survival
Kaplan-Meier curves for MACE-free survival in the positive and negative groups. The frequency of MACE-free survival was significantly lower in the positive group than in the negative group (p ϭ 0.0018). ACh ϭ acetylcholine; MACE ϭ major adverse cardiac events. 
